7:50am ET
Health and Healthcare
Major Biotechs See Increased Short Interest Bets
The short interest data are out for the July 15 settlement date. Short interest increased across many of these selected biotech stocks.
Companies
/Healthcare
Gilead Sciences Inc
$148.09
▼ $0.68 (−0.46%) today
Markets closed · 10:56pm ET
GILD Coverage
Page 2711:50am ET
Health and Healthcare
Why Analysts Are Thinking M&A Is Back on the Table for Gilead
Overall, the Gilead Sciences report was not good and investors took to dumping the stock. On the other hand, this could provide a buying opportunity since shares are just off of their…
Chris Lange 8:50am ET
Investing
Top Analyst Upgrades and Downgrades: Gilead, Sprint, Starbucks, Southwest Air, Texas Instruments, Disney, Nordstrom and More
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Gilead Sciences, Sprint, Starbucks, Southwest Airlines, Texas Instruments, Walt Disney and Nordstrom.
4:37pm ET
Health and Healthcare
Why Analysts Were Not Satisfied With Gilead Earnings
Although Gilead Sciences is one of the world’s leading biotech companies, an earnings beat in its latest report was not enough to satisfy investors.
Chris Lange 9:05am ET
Health and Healthcare
What to Expect From Gilead Sciences Earnings
Gilead Sciences is scheduled to release its second-quarter financial results after the markets close on Monday.
Chris Lange 10:12am ET
Investing
10 Must-See Earnings for the Coming Week
24/7 Wall St. has put together a preview of Alphabet, Amazon.com, Facebook and some of the other major companies reporting their quarterly results this week.
8:40am ET
Investing
5 Companies Likely Buying Back the Most Stock in June and July
With many stocks having just hit record highs, investors need at least a bit of an explanation here. One thing likely contributing to the gains is the endless effort in share buybacks…
8:10am ET
Health and Healthcare
Short Sellers Become More Selective on Major Biotechs
The June 30 short interest data have been compared with the previous report, and short interest moves were mixed in these selected biotech stocks.
10:10am ET
Health and Healthcare
Biotechs With Drug Pipelines Closest to Zero Valuation
Credit Suisse has taken a look at which biotech companies in its coverage have the least credit given to pipeline potential at current levels.
12:01pm ET
Health and Healthcare
5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero
Sometimes market volatility and outside shocks create a rift between market prices and real value. That may currently be the case in the largest stocks in the biotech sector within health care if RBC…
7:55am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The short interest data are out for the June 15 settlement date. Biotech companies are considered a riskier group of stocks, with big potential upside and big potential downside. After all, a…
8:05am ET
Investing
20 Companies Buying Back the Most Stock in 2016
Standard & Poor's has now shown that the first quarter of 2016 saw a 12% rise in buyback spending to a whopping $161.4 billion.
12:25pm ET
Health and Healthcare
Gilead Sciences Bounces on Preliminary Results
Shares of Gilead Sciences Inc. (NASDAQ: GILD) saw make a handy gain just off of their 52-week low following the release of preliminary data from its HIV treatment. After the stock dropped about 17.5%…
Chris Lange 8:10am ET
Health and Healthcare
Short Sellers Become More Selective on Major Biotechs
The May 31 short interest data have been compared with the previous report, and short interest moves were mixed in these selected biotech stocks.
8:10am ET
Health and Healthcare
7 Companies in the Fight to Defeat the Zika Virus
Many companies are being discussed as Zika virus winners, but the reality is that many of them are so small or have sketchy histories. This is why we are featuring seven notable…